Klinik für Innere Medizin IHämatologie, Onkologie und Stammzelltransplantation

Scientific focus

Our research focus is the investigation of genetics and epigenetics of myeloid disorders and solid cancers. Genetic and epigenetic aberrations drive cancerogenesis and shape the clonal composition of malignancies. Intracellular mechanisms and the clonal composition are crucial for sensitivity or resistance of a given cancer treatment. In addition, aberrant myeloid-derived blood cells have been recognized as important contributors to the pathogenesis of solid cancers and other non-hematologic disorders. Our overarching goal is to better understand the genetic/epigenetic clonal architecture of cancers and blood disorders and the changes under treatment, and to identify biological mechanisms and predictive markers associated with primary or secondary resistance to treatment, and to use this knowledge to improve patient care.

Open Positions

Applications are always welcome! PhD and MD student positions are available in projects focusing on epigenetic biomarkers and treatment. Please send your email to heiko.becker@uniklinik-freiburg.de